China Medical University Hospital
Taichung, North District, 40447, Taiwan
NCT Number: NCT05247762
The goal of this clinical trial is to test the therapeutic effect of acupuncture at the Jingming and the Qiuhou acupoints on the visual acuity and visual field in patients with primary open-angle glaucoma.
Participants will get acupuncture or Wangbuliu Xingzi Paste (sham acupuncture) on both sides of the Jingming and the Qiuhou, once a week, once for 20 minutes, for 24 weeks.
Researchers will compare acupuncture group and sham acupuncture group to see if the visual acuity, visual field, intraocular pressure, optic nerve fiber layer thickness, serum homocysteine concentration, and scores on the WHOQOL-REF (Taiwan version) scale would be improved.
Looking for future studies?
Notify Me20 year–75 year
All sexes
Interventional
Not applicable
Taichung, North District, 40447, Taiwan
Glaucoma is a syndrome. The long-term increase in intraocular pressure eventually leads to visual field defect and blindness. Lowering the intraocular pressure in patients with glaucoma is considered to be the most effective way to treat glaucoma. Many studies believe that both blood circulation around the eyes and increased intraocular pressure play a critical role in glaucoma. Some studies have shown that acupuncture can adjust intraocular pressure and improve optic nerve activity, as well as increase blood flow of the eye fundus. Jingming (BL1) can communicate yin and yang, nourish and improve eyesight, and Qiuhou (EX-HN7) can promote qi and blood circulation, and improve vision. The results of our previous research found that acupuncture or electroacupuncture can reduce the intraocular pressure in patients with glaucoma. Therefore, the purpose of this study is to assess the therapeutic effect of acupuncture at the Jingming and the Qiuhou acupoints on the visual acuity and visual field in patients with primary open-angle glaucoma. This study designed a randomized, single-blind, controlled clinical trial. A total of 40 patients with primary open-angle glaucoma were randomly divided into two groups equally as follows: 1) Sham acupuncture group: Only use Wangbuliu Xingzi Paste on the skin on the acupoints on both sides of the Jingming and the Qiuhou, once a week, once for 20 minutes, for 24 weeks; 2) Acupuncture group: The method is the same as the sham acupuncture group, but the stainless steel needles are used to insert into the two points of Jingming and the Qiuhou, and der-qi, once a week, once for 20 minutes, for 24 consecutive weeks. The main assessment is visual acuity and visual field; the secondary assessment includes intraocular pressure, optic nerve fiber layer thickness, serum homocysteine concentration, and changes in scores on the WHOQOL-REF (Taiwan version) scale.
It is expected that acupuncture intervention can improve the visual acuity and visual field in patients with glaucoma.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The stainless steel needles are used to insert into the two points of Jingming and the Qiuhou, and der-qi, once a week, once for 20 minutes, for 24 consecutive weeks.
Time frame: 24 weeks
Primary outcome measure was the changes of visual acuity
Time frame: 24 weeks
Primary outcome measure was the changes of visual field
Time frame: 24 weeks
Secondary outcome measure was the changes of intraocular pressure
Time frame: 24 weeks
Secondary outcome measure was the changes of optic nerve fiber layer thickness
Time frame: 24 weeks
Secondary outcome measure was the changes of serum homocysteine concentration
Time frame: 24 weeks
Secondary outcome measure was the changes of the World Health Organization Quality of Life brief (Taiwan version) scale. The score is between 0-140, and higher score means better life quality.
China Medical University Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03651336
Cataract, Eye Diseases
Aachen, Germany
View Trial DetailsNCT04519814
Eye Diseases, Glaucoma
Dresden, Germany
View Trial DetailsNCT05253534
Eye Diseases, Glaucoma
Izmir, Turkey (Türkiye)
View Trial DetailsNCT04333433
Eye Diseases, Glaucoma
Glendale, Arizona, United States
View Trial Details